New Gavi Risk Sharing Partnership with MedAccess and the Open Society Foundations to help meet country demand for COVID-19 vaccines
07. April 2022 02:00 ET
|
Open Society Foundations
New York, April 07, 2022 (GLOBE NEWSWIRE) -- Gavi, MedAccess, and the Open Society Foundations announce a new partnership to create an innovative Risk Sharing Facility to support the COVAX...
Dyadic Announces Technology Transfer and Licensing Agreement With South Africa’s Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent
27. Juli 2021 08:20 ET
|
Dyadic International, Inc.
Arrangement includes C1 COVID-19 vaccine technology transfer and licensing agreementProvides potential funding pathway for a C1 manufactured COVID-19 vaccine to progress through Phase II and Phase III...
Hatch raises C$1 million for COVAX and UNICEF
07. Juli 2021 06:32 ET
|
Hatch Ltd
Mississauga, Canada, July 07, 2021 (GLOBE NEWSWIRE) -- Mississauga, Canada— Hatch employees came together in an eight-week-long campaign to raise funds in support of COVAX, helping them progress...
Canadian business and philanthropic leaders call on their peers to #ShareTheHealth and donate to UNICEF’s COVID-19 Global Vaccination Efforts
27. Mai 2021 08:30 ET
|
UNICEF Canada
Toronto, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- Today, 16 senior leaders from top Canadian companies and foundations, including Teck Resources Limited and Fairmount Foundation, released an Open...
UPS Healthcare and The UPS Foundation make financial and in-kind commitment to facilitate equitable worldwide vaccine deliveries
04. März 2021 00:00 ET
|
UPS
Initial commitment for delivery of 20 million doses to countries in need across four continentsKey support for equitable vaccine distribution through COVAX, Gavi, the vaccine alliance and CARE’s Fast...
Pfizer und BioNTech erzielen Vereinbarung mit COVAX für Vorabkauf von Impfstoff zur Bekämpfung von COVID-19
22. Januar 2021 12:00 ET
|
BioNTech SE
Initiale Vereinbarung über Bereitstellung von bis zu 40 Millionen Impfstoffdosen an die COVAX-Initiative im Jahr 2021Erste Lieferungen sollen im ersten Quartal 2021 beginnen, vorbehaltlich der...
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
22. Januar 2021 12:00 ET
|
BioNTech SE
Initial agreement provides up to 40 million doses to COVAX in 2021First deliveries are expected to take place in Q1 2021 subject to the execution of supply agreements under the COVAX Facility...